An observational study in Mitral Regurgitation, sponsored by Mi Chen. Active, not recruiting at 3 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-08.
Sponsored by Mi Chen · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 63 studies in Mitral Valve Insufficiency with a site in Italy — 20 open to participants now, 28 under way, none of them phase 3. Mitral Valve Insufficiency · Italy.
Among the 63 studies in Mitral Valve Insufficiency with a site in Italy, this one is the 2nd largest by planned enrollment of the 33 observational ones that give a count, is one of 6 that started in 2025, is one of 33 observational ones, reaches primary completion later than 14 of the 27 other live ones, and was the 63rd registered.
471 studies on the registry are indexed under Mitral Valve Insufficiency; 165 are open to participants now.
Browse Mitral Valve Insufficiency studies →20 of the 63 studies in Mitral Valve Insufficiency with a site in Italy are open now. Recruiting first, the newest first:
Centro Cardiologico Monzino · Sites in Italy
Ages 18+
ASL Città di Torino · Sites in Italy, Belgium
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Sites in Italy
Ages 18+
Medical University of Vienna · Sites in Italy, Austria, Germany and 1 more country
Ages 18+
Fundación para la Investigación Biosanitaria del Principado de Asturias · Sites in Italy, Israel, Netherlands and 1 more country
Ages 18–99
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 121 Mitral Valve Insufficiency studies recruiting now, 100 (83%) set no upper age limit and 6 (5%) stop at 75 or younger; 12 take children under 18; 1 takes healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
63 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 6 started in 2025.
This study's planned enrollment of 1,500 is above the median of 159 across 170 observational studies indexed under Mitral Valve Insufficiency.
Median enrollment 95 across the 30 interventional studies, 200 across the 33 observational. Of the 24 that completed or were terminated, 7 (29%) have results posted.
This tab as a report to print or save as PDF → With an account.
28 of 63 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Mi Chen as lead sponsor.
Mi Chen has 1 study filed under Mitral Valve Insufficiency — fewer than ten, so there is no comparison to draw.
5 of the studies in Mitral Valve Insufficiency with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07632794Mi ChenArtificial Intelligence Assisting Transcatheter Mitral Edge-to-Edge Repair | 2026-12-31 |
| NCT03339115Cardiovalve Ltd.AHEAD: European Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System | 2026-12-31 |
| NCT03142152Cardiac Dimensions, Inc.The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR | 2026-12-31 |
| NCT04898335LMU KlinikumTendyne European Experience Registry | 2026-12-31 |
| NCT06282042Fundación para la Investigación Biosanitaria del Principado de AsturiasEarly Transcatheter Mitral Valve Repair After Myocardial Infarction | 2027-06-16 |
Add all 5 to your calendar (.ics) → With an account.
Among the 63 studies in Mitral Valve Insufficiency with a site in Italy, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This multicenter, retrospective study develops and validates artificial intelligence (AI)-based semantic segmentation algorithms for intraprocedural transesophageal echocardiography (TEE) during Transcatheter Mitral Edge-to-Edge Repair (TEER). Using pooled imaging data from multiple high-volume structural heart centers, the study aims to automate recognition of mitral leaflets and MitraClip components, measure leaflet insertion length in real time, and display clip position and orientation. Algorithm performance will be benchmarked against expert manual annotations.
Transcatheter Mitral Edge-to-Edge Repair (TEER) with the MitraClip device is an established minimally invasive treatment for patients with severe mitral regurgitation who are at high surgical risk. The success of TEER relies heavily on real-time transesophageal echocardiography (TEE) to guide precise clip positioning and leaflet capture. However, intraoperative image interpretation remains highly dependent on operator experience, and variability in image quality, patient anatomy, and the dynamic nature of cardiac structures continue to challenge procedural standardization across centers.
This multicenter, retrospective imaging study evaluates whether artificial intelligence (AI)-based semantic segmentation can automate the recognition of mitral valve anatomy and MitraClip device components on intraprocedural TEE images. Previously acquired TEE imaging from adult patients who underwent TEER at multiple participating high-volume structural heart centers will be pooled and analyzed. All data are derived from routine clinical care, and only patients with appropriate consent for research use of their clinical and imaging data are included.
The study has three objectives: (1) to develop deep learning models that automatically segment the anterior and posterior mitral leaflets and the MitraClip grippers and arms; (2) to automate real-time measurement of leaflet insertion length during the grasping process; and (3) to integrate three-dimensional imaging with intelligent tracking to display clip position and orientation. By drawing on a multicenter dataset, the study aims to improve the generalizability and robustness of the resulting models across diverse imaging environments, operator practices, and patient anatomies. Algorithm performance will be benchmarked against expert manual annotations using established image segmentation metrics.
The study population consists of adult patients with degenerative or functional mitral regurgitation who underwent Transcatheter Mitral Edge-to-Edge Repair (TEER) with the MitraClip device at multiple participating high-volume structural heart centers. All data are derived from routine clinical care, including intraprocedural transesophageal echocardiographic (TEE) imaging and corresponding clinical records. Only patients with appropriate consent for research use of their data, as defined by the policy of each participating center, are included. The cohort reflects real-world TEER practice across diverse imaging environments, operator experience, and patient anatomies, supporting the development and validation of artificial intelligence-based segmentation and measurement tools with improved generalizability.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Accuracy of AI-based semantic segmentation of mitral valve leaflets and MitraClip device components
The accuracy of the deep learning model in segmenting the anterior and posterior mitral leaflets, MitraClip grippers, and clip arms on intraprocedural transesophageal echocardiography (TEE) images. Performance is benchmarked against manual annotations provided by experienced echocardiographers and quantified using the Dice similarity coefficient, sensitivity, and specificity. Target performance: ≥ 90%.
Time frame: Intraprocedural (TEE images acquired during the TEER procedure)
Accuracy of automated real-time recognition of mitral leaflet insertion length
The accuracy of the automated measurement system in recognizing the insertion length of the anterior and posterior mitral leaflets in two-dimensional TEE planes during the leaflet grasping process. Algorithm output is compared with manual measurements performed by experienced echocardiographers. Target performance: ≥ 95%.
Time frame: Intraprocedural (TEE images acquired during the TEER procedure)
Plan to share: No — Individual participant data will not be shared. All clinical and imaging data are pseudonymized and stored under restricted access in accordance with the approved study protocol, applicable data protection regulations (Swiss Human Research Act, Swiss Federal Act on Data Protection, and applicable regulations at each participating center), and the sponsor's data governance policy. Aggregated and anonymized results will be disseminated through peer-reviewed publications and scientific presentations.
No publications or documents are linked to this record.
Started Sep 2025 (actual). Primary completion is estimated for Dec 2026, 15 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.